Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Molendotech Limited currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. The prosecution is split between 2 distinct examiners and 2 distinct art units. This structure indicates that each pending matter is being handled by a different official in a different technical division, preventing any consolidation of strategy across the current workload. The use of 2 distinct art units suggests the company's innovations are categorized into different biological or pharmaceutical specialties.
The busiest examiner, KARUNASENA, ENUSHA, is assigned 1 busiest examiner pending action. Since the total number of pending office actions is 2, this examiner's workload represents a portion of the active matters. Practitioners must navigate the distinct procedural styles of 2 distinct examiners, as no individual official dominates the current portfolio activity. The lack of overlap between the examiners means that success in an application may not necessarily provide a roadmap for the other pending matter. Understanding the specific tendencies of KARUNASENA, ENUSHA is essential for managing this specific pending office action.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KARUNASENA, ENUSHA | 1 | 25.0% | +100.0% |
| GERIDO, DWAN A | 1 | 58.1% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009879 | TESTING METHOD AND APPARATUS | KARUNASENA, ENUSHA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16962319 | WATER QUALITY TESTING | GERIDO, DWAN A | 26d |
| 18009879 | TESTING METHOD AND APPARATUS | KARUNASENA, ENUSHA | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18009879 | TESTING METHOD AND APPARATUS | KARUNASENA, ENUSHA | 1645 | §103 | Non-Final OA | — | Pending | Dec 12, 2022 |
| 16962319 | WATER QUALITY TESTING | GERIDO, DWAN A | 1797 | §103 | Final Rejection | 26d | Pending | Jul 15, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMolendotech Limited has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Enusha Karunasena has the most, with 1 of Molendotech Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
